Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (271-280 of 378) with videos related to

Pageof 38
Sort By:
The American Journal of Cardiology|July 6, 2013
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stentsHironori Kitabata, Joshua P Loh, Lakshmana K Pendyala, et al.
The American Journal of Cardiology|March 10, 2009
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantationProbal Roy, Laurent Bonello, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 10, 2016
Vascular access in critical limb ischemiaWon Yu Kang, Umberto Campia, Hideaki Ota, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2008
Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarctionTina L Pinto Slottow, Daniel H Steinberg, Probal Roy, et al.
The American Journal of Cardiology|February 24, 2006
Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Seung-Woon Rha, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 28, 2017
Intraprocedural invasive hemodynamic parameters as predictors of short- and long-term outcomes in patients undergoing transcatheter aortic valve replacementSarkis Kiramijyan, Edward Koifman, Marco A Magalhaes, et al.
The American Journal of Cardiology|August 19, 2007
Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deploymentTeruo Okabe, Gary S Mintz, Ashesh N Buch, et al.
The American Journal of Cardiology|July 22, 2008
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry)Probal Roy, Laurent Bonello, Axel de Labriolle, et al.
The American Journal of Cardiology|November 11, 2008
Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary interventionLaurent Bonello, Gilles Lemesle, Axel De Labriolle, et al.
The American Journal of Cardiology|July 26, 2011
Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulationRafael Romaguera, Gabriel Sardi, Ana Laynez-Carnicero, et al.
Pageof 38

Showing results (271-280 of 378) with videos related to

Sort By:
Pageof 38
The American Journal of Cardiology|July 6, 2013
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stentsHironori Kitabata, Joshua P Loh, Lakshmana K Pendyala, et al.
The American Journal of Cardiology|March 10, 2009
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantationProbal Roy, Laurent Bonello, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 10, 2016
Vascular access in critical limb ischemiaWon Yu Kang, Umberto Campia, Hideaki Ota, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2008
Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarctionTina L Pinto Slottow, Daniel H Steinberg, Probal Roy, et al.
The American Journal of Cardiology|February 24, 2006
Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Seung-Woon Rha, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 28, 2017
Intraprocedural invasive hemodynamic parameters as predictors of short- and long-term outcomes in patients undergoing transcatheter aortic valve replacementSarkis Kiramijyan, Edward Koifman, Marco A Magalhaes, et al.
The American Journal of Cardiology|August 19, 2007
Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deploymentTeruo Okabe, Gary S Mintz, Ashesh N Buch, et al.
The American Journal of Cardiology|July 22, 2008
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry)Probal Roy, Laurent Bonello, Axel de Labriolle, et al.
The American Journal of Cardiology|November 11, 2008
Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary interventionLaurent Bonello, Gilles Lemesle, Axel De Labriolle, et al.
The American Journal of Cardiology|July 26, 2011
Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulationRafael Romaguera, Gabriel Sardi, Ana Laynez-Carnicero, et al.
Pageof 38